ECP 2023 Final Programme

Monday, 11 Sept Scientific Programme a Monday 39 ECP 2023 Dublin e Monday, 11 September 2023 SY-05 Symposium 08:30–12:00 The Auditorium Digestive Diseases Pathology – GI Joint Symposium Digestive Diseases Pathology (GI) & Rodger Haggitt GIPS: The varied histological types of GI tract epithelial neoplasms Chairs: Roger Feakins, United Kingdom Jinru Shia, USA 001 08:30–08:55 Squamous lesions and other rare tumours of the columnar-lined GI tract: when do we expect to see them? Raul Gonzalez, USA 002 08:55–09:20 Appendiceal adenocarcinomas: an update Amitabh Srivastava, USA 003 09:20–09:30 Discussion – Part I 004 10:30–10:50 Mucinous carcinoma of the upper and lower GI tract: what is it, and when does it matter? Magali Svrcek, France 005 10:50–11:10 Neuroendocrine carcinomas of the columnar-lined GI tract: are they all fundamentally adenocarcinomas? Deepti Dhall, USA 006 11:10–11:30 Colorectal adenocarcinoma: site vs. tumour phenotypic traits Maurice Loughrey, United Kingdom 007 11:30–11:50 Lymphocyte-rich GI tract carcinomas: commonalities and distinctions Fátima Carneiro, Portugal 008 11:50–12:00 Discussion – Part II SY-06 Symposium 08:30–12:00 Liffey B Gynaecological Pathology Advances in ancillary techniques in gynaecological pathology Chairs: Maria Rosaria Raspollini, Italy David Hardisson, Spain 001 08:30–09:05 Molecular pathology – trophoblastic, adnexal and uterine mesenchymal tumours Mojgan Devouassoux-Shisheboran, France 002 09:05–09:30 Molecular pathology – carcinomas of the uterine corpus, cervix, vagina and vulva Jose Palacios Calvo, Spain 003 10:30–10:55 Immunohistochemistry – Lower genital tract Glenn McCluggage, United Kingdom 004 10:55–11:20 Immunohistochemistry – Upper genital tract Esther Oliva, USA 005 11:20–11:50 Novel approaches – experimental models derived from the fallopian tubes and geospatial imaging of fallopian tube precursors Ronny Drapkin, USA 006 11:50–12:00 Q&A SY-07 Symposium 08:30–12:00 Liffey A Haematopathology Technological advances in the diagnosis of haematological malignancy Chairs: Falko Fend, Germany Stefan Dirnhofer, Switzerland 001 08:30–09:00 The molecular classification of MDS/AML? Robert Hasserjian, USA 002 09:00–09:30 The molecular landscape of DLBCL Stefan Dirnhofer, Switzerland